Alberto del Rio Espinola is Director of Translational Sciences at GentiBio. He holds Biotechnology and Biochemistry degrees from Autonoma de Barcelona University and his PhD in pharmacogenetics of stroke acute therapy from Vall d’Hebron Hospital. During his time with Novartis in Basel, Switzerland, Alberto started as a computational biologist applying pharmacogenetics to safety endpoints, he went on to work in a project toxicologist role for advanced therapy programs then led a laboratory using genome engineering as a tool to support safety evaluation. Alberto is certified by American Board of Toxicology and by European Registry. In his free time, Alberto enjoys swimming in the Rhein, cooking and growing food, and spending time with friends, and his partner and their little toddler.
Alberto del Rio Espinola, PhD
Director, Translational Sciences
